The PRECEDE consortium: A longitudinal international cohort study of individuals with genetic risk or familial pancreatic cancer.
George Zogopoulos(McGill University Health Centre), Diane M. Simeone(UC San Diego Health System), Aimee L. Lucas(Icahn School of Medicine at Mount Sinai), Fay Kastrinos(Columbia University Irving Medical Center), Bryson W. Katona(University of Pennsylvania), Yan Bi, Jennifer B. Permuth(Moffitt Cancer Center), Randall E. Brand(University of Pittsburgh), James J. Farrell(Yale University), Salvatore Paiella(University of Verona), Sonia S. Kupfer(University of Chicago), Julie Earl(Instituto Cajal), Rosalie C. Sears(Oregon Health & Science University), Daniel C. Chung(Massachusetts General Hospital), Andrew M. Lowy(UC San Diego Health System), Cathryn Koptiuch(University of Utah), John J. Graff(Arbor Research Collaborative for Health), Richard S. Kwon(University of Michigan), James Lindberg, Kelsey Klute
Cited by 2
Related Papers
Identification of Pancreatic Cancer Stem Cells
|Cancer Research|2007|3.4k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k